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A complete silence. That was what we got back from the European experts that had been 
energetically discussing research priorities in palliative care in neurodegenerative disease (ND)  until 
a short while ago.1 The chair, an entertaining professor with good manners, must have felt the 
unease and quickly refocused the group to their task. But, wasn’t this the best question of all day? 
What research we no longer need? As scientists able to consider different perspectives, shouldn’t we 
have some idea of what research is, by contrast, no longer necessary?   
Palliative care research, and research with people who have ND and are at the end of their 
life is by definition, difficult. Making choices is a sensitive issue, but funds are limited. Therefore, we 
take a counterpoint to the research agenda recently reported by EU Joint Programme-
Neurodegenerative Disease Research (JPND), 1 and consider whether there are studies we no longer 
need or are low priority, taking the example of dementia.  
 
The growth of palliative care research for people with dementia  
At the end of life or earlier, people with dementia may benefit from palliative care. Some evidence 
suggests that hospice care or a palliative approach improves families’ satisfaction with care although 
benefits for patients are less clear.2-5  
Early research from the US (80-ies)6 focused on the development of hospice for people with 
dementia. In the UK, early work described care and symptoms (90-ies).7,8 Research in dementia at the 
end of life has exponentially increased since the turn of the century, with more countries developing 
research programmes9-11 and narrative reviews appearing in a variety of specialty journals. Although 
high-quality evidence of effects or effective elements of palliative care in dementia is still sparse, 
currently, there is a consensus that it is helpful in the advanced stages.12   
We are arguably at a turning point as different research disciplines that have had a limited 
exposure to research on palliative care in dementia (for example, social gerontologists, 
psychogeriatricians, ethicists and health services researchers) recognize that they have an important 
contribution to make. One challenge is how to expand the involvement of the research community 
and build capacity while ensuring that research is not inadvertently duplicated.. The burgeoning of 
qualitative research on the experience of becoming a person with dementia is a vivid example of how 
a research question that is recognised as important can inadvertently lead to avoidable duplication.  
A systematic review of qualitative research reviewed 126 papers and concluded that the common 
statement that the person with dementia’s voice is not heard is not true if applied to white educated 
people who live with a carer.13 What might be the equivalent situation at the opposite end of the 
disease trajectory? 
 
How to improve design and theory and build a sound evidence base 
We suggest how to progress research on dementia at the end of life (online Box 1) by focusing on 
three broad areas of concern and s. These are (1) the use and contribution of theory, (2) the 
limitations of particular research designs and (3) how the evidence base develops and is applied. We 
first illustrate the three areas in how research on advance care planning (ACP) is approached and 
then discuss other examples addressing the three areas separately.  
Research on ACP  is “hot.” It is seen as the means by which professionals in partnership with 
patients and their families can address the uncertainties that arise at the end of life, especially when 
patients cannot participate in decision making.10,14 To develop theory (1), we need to compare long-
term effects of different advance care planning interventions (1a in Box 1). Pragmatic approaches are 
needed because patients with dementia will, at some point, no longer be able to revise their plans. 
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However, without sufficient breadth of understanding to support how ACP is introduced throughout 
the disease trajectory, we cannot design more sophisticated research (2b). Research also needs to 
address unintended consequences of planning ahead10,15,16 (3a) and interventions need to be 
sensitive to time, place, culture and particular populations. Furthermore, we need full reports of 
“negative” findings to avoid duplication, but also replication of the best studies in different settings 
(3c). For example, using the same instruments, we found that families’ understanding of prognosis in 
the Netherlands was unrelated to aggressive treatment as found in the US.17 However, we neglected 
to report in full this important dissonant finding, only reporting it in a single sentence in the 
discussion of a paper addressing a different research question.18 The findings do suggest that family 
education may work better in one country than in the other, and this example shows how an 
emphasis on “positive findings” and lack of full reporting of replication, risks compromising the 
evidence base.  
 
The  use and contribution of theory  
We do not need more research that concludes palliative care for people with dementia is complex 
and context specific, which does not help build theory (Box 1, area 1). Too often, research for people 
with dementia at the end of life borrows the assumptions of what is good care from cancer models, 
whilst simultaneously acknowledging their limitations. It does not discuss or analyse what elements 
are transferable and which are not.19 We should consider what is already known about interventions 
that ameliorate the impact of frailty, old age, other chronic-progressive diseases and implementation 
research in long-term care. For example, research on continuity of care for people with long-term 
conditions is highly relevant for how palliative care for people with dementia is delivered over time.20 
In contrast to the often a-theoretical approaches of ACP research, the example of research 
on spirituality has arguably given too much to theorizing and too little to implementation (Box 1, 1b). 
Research on what spiritual care is, needs to consider how and if integration into palliative care 
models achieves better outcomes for patients and their caregivers. 
 
The limitations of uni-dimensional research design or analysis 
Although it may be appropriate  for countries with no tradition of research in the area, the 
international research community should be increasingly wary of studies that describe the challenges 
of symptom assessment in advanced dementia, family burdens, or staff knowledge of palliative care 
and conclude that more research or single-solution interventions are needed (Box 1, 2a). Palliative 
care research, particularly for populations whose dying trajectory is protracted, faces particular 
challenges in establishing causality. If it is not possible to establish causality or effectiveness9,21 then 
we need to expand our portfolio of research methods (2b). Most palliative care interventions are 
multi component. We should be able to pinpoint relevant findings and determine which findings are 
generalizable, or at least show potential, and which do not, for example, through adequately 
powered parallel studies, mediator analyses or thorough evaluation of implementation.22  
 In dementia research it is problematic researching highly selected populations, such as those 
limited to the terminal or severe disease stages or truncation in prospective studies that is not 
anchored in the disease trajectory (Box 1, 2c). It does not reflect the fact that many people die with 
dementia as a concomitant disease as well as from it, and that the dying trajectory is intrinsically 
uncertain, with palliative care needs arising along the disease trajectory. A narrow focus does not 
allow for studying changes in the course of the disease and the nature of optimal palliative care and 
anticipating changes and needs in each phase.  Further, given what we know about the significance 
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of transitions through stages and settings, studies in single settings can only offer a partial account.  
For example, contrasting interventions in  home care and long-term care has important benefits in 
terms of informing future policy. 
 
Implementation based on a sound evidence base 
In general, we may focus too much on innovative research (Box 1, 3a). Replication, not only 
collaborative parallel studies but also independent replication, is needed to understand 
generalizability of findings.23 How else do we know if the researchers’ enthusiasm affected their 
independence or critical distance and subsequently the reporting and publication of these studies? 
Optimism bias relates to distorted evidence or the reporting of “promising” results that need further 
testing.24  We do not need research that is implemented too soon without replication with valuable 
learning lost in the process, or is not published in full or remains unpublished because of “neutral” or 
“negative findings.”25 Publication bias is an issue also in qualitative research, where striking or clear 
findings are over reported.26 To advance the wider evidence base on palliative care, we may evaluate 
reporting bias in palliative care research and incentives for replication studies and publishing 
“negative” findings. 
Conclusion 
We took dementia as an example to indicate what research in palliative care in ND we no longer 
need, considering the use of theory, study design, and the wider evidence base. Poorly designed, 
stand-alone descriptive, uncontrolled and underpowered studies or those not targeting the right 
questions or that remain unpublished are always a waste of resource.27 To develop palliative care in 
ND, in addition to a trans-setting and trans-stages-of-disease approach, we need a trans-disease 
approach. We need a cross fertilization in research ideas and approaches to understand how 
palliative care principles should be applied in different diseases. A programmatic approach covering a 
series of interlocking studies may help to efficiently build capacity and design the studies we need.19 
This is not an attack on colleagues and we are aware that some of the research we state is no 
longer needed, we have recently undertaken. The platform of JPND to generate a trans-European 
research agenda for palliative care in ND was the trigger, an opportunity to consider what we have 
learnt. To suggest that some research is no longer needed, should be a cause for celebration.  Our 
reflections complement the JPND report1 and hopefully support palliative care research for people 
with ND and their caregivers, that leads to cross-national and interdisciplinary collaborations and 
building the next generation of research.  
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